Skip to main content
. 2019 Feb 27;58(11):1923–1927. doi: 10.1093/rheumatology/kez028

Table 1.

Baseline characteristics of participants in the PAALS study

All participants (n = 2477) Participants who completed clinical assessment and provided full data (n = 194)
Female, n (%, 95% CI) 1549, (63, 61, 65) 122, (63, 56, 70)
Age, median (IQR) 64 (55–74) 66.5 (59–78)
Fatigue (CFQ, 0–33), median (IQR) (n=2272) 12 (11–16) 12 (11–16)
MSK Pain (number of sites 0–29), median (IQR) (n=2463) 3 (0–8) 3 (0–6)
Depression (HADS; 0–21), median (IQR) (n=2285) 4 (2–7) 4 (2–7)
Anxiety (HADS; 0–21), median (IQR) (n=2271) 5 (2–8) 5 (2–7)
Sub-optimal PA, n (%, 95% CI) (n=2346) 1278 (55, 53, 57) 112, (58, 51, 65)
Number of current medications, median (IQR) 2 (0–5) 3 (1–5)
WUR-H, median (IQR) 2.3 (1.5, 4.0)
WUR-F, median (IQR) 2.4 (1.6, 3.9)
% Body fat, median (IQR) 31.8 (25.1–38.5)

95% CI: 95% confidence interval; CFQ: Chalder Fatigue Scale; HADS: Hospital Anxiety and Depression Scale; RAPA: Rapid Assessment of Physical Activity; IQR: interquartile range; MSK: musculoskeletal; WUR-H: wind-up ratio test at the hand; WUR-F: wind-up ratio test at the foot; PAALS: Pain Across the Adult Life Span; PA: Physical Activity.